![Daniel M. Jorgensen](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Daniel M. Jorgensen
Technik-/Wissenschafts-/F&E-Leiter bei Ocugen OpCo, Inc.
Aktive Positionen von Daniel M. Jorgensen
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Ocugen OpCo, Inc. | Technik-/Wissenschafts-/F&E-Leiter | 01.04.2017 | - |
Karriereverlauf von Daniel M. Jorgensen
Ehemalige bekannte Positionen von Daniel M. Jorgensen
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Critical Path Institute
![]() Critical Path Institute Miscellaneous Commercial ServicesCommercial Services Critical Path Institute is a nonprofit organization established in 2005 as a public and private partnership with the FDA's Critical Path Initiative program. The non-profit company is based in Tucson, AZ, and operates from Ireland with additional staff in multiple other locations. The company's mission is to catalyze the development of new approaches that advance medical innovation and regulatory science, accelerating the path to a healthier world. The company orchestrates the development of drug development tools through an innovative, collaborative approach to the sharing of data and expertise, and accelerate the pace and reduce the costs of medical product development by building consensus among the participating institutions. The company was founded in 2005 by Raymond L. Woosley, Glenn C. Rice. Daniel M. Jorgensen has been the CEO of the company since 2022. | Vorstandsvorsitzender | 01.10.2022 | 09.01.2024 |
OCUGEN, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.04.2017 | 15.07.2020 |
Finch Research & Development LLC
![]() Finch Research & Development LLC Pharmaceuticals: MajorHealth Technology Part of Finch Therapeutics Group, Inc., Finch Research & Development LLC provides biopharmaceutical services. The company is based in Cambridge, MA. Finch Research & Development was acquired by Finch Therapeutics, Inc. on October 23, 2017. | Technik-/Wissenschafts-/F&E-Leiter | 01.04.2016 | 01.04.2017 |
INNOVATION PHARMACEUTICALS INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2015 | 01.03.2016 |
Centers for Disease Control & Prevention
![]() Centers for Disease Control & Prevention General GovernmentGovernment Centers for Disease Control and Prevention operates as a government health center. It helps to prevent and control infectious and chronic diseases, injuries, workplace hazards, disabilities and environmental health threats. It conducts research and investigations for its action oriented approach. The company was founded on July 1, 1946 and is located in Atlanta, GA. | Corporate Officer/Principal | - | - |
SANUWAVE HEALTH, INC. | Technik-/Wissenschafts-/F&E-Leiter | 14.05.2013 | - |
POLYMEDIX, INC. | Technik-/Wissenschafts-/F&E-Leiter | 02.09.2011 | - |
Ausbildung von Daniel M. Jorgensen
University of Washington | Graduate Degree |
Yale University | Masters Business Admin |
University of Wisconsin | Doctorate Degree |
Statistik
International
Vereinigte Staaten | 12 |
Operativ
Chief Tech/Sci/R&D Officer | 6 |
Doctorate Degree | 1 |
Masters Business Admin | 1 |
Sektoral
Health Technology | 6 |
Consumer Services | 4 |
Government | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 3 |
---|---|
INNOVATION PHARMACEUTICALS INC. | Health Technology |
SANUWAVE HEALTH, INC. | Health Technology |
OCUGEN, INC. | Health Technology |
Private Unternehmen | 5 |
---|---|
PolyMedix, Inc.
![]() PolyMedix, Inc. Pharmaceuticals: MajorHealth Technology PolyMedix, Inc. engaged in developing first-in-class, small-molecule defensin-mimetics for the treatment of serious acute care conditions. The company was founded in 2002 and was headquartered in Radnor, PA. | Health Technology |
Centers for Disease Control & Prevention
![]() Centers for Disease Control & Prevention General GovernmentGovernment Centers for Disease Control and Prevention operates as a government health center. It helps to prevent and control infectious and chronic diseases, injuries, workplace hazards, disabilities and environmental health threats. It conducts research and investigations for its action oriented approach. The company was founded on July 1, 1946 and is located in Atlanta, GA. | Government |
Critical Path Institute
![]() Critical Path Institute Miscellaneous Commercial ServicesCommercial Services Critical Path Institute is a nonprofit organization established in 2005 as a public and private partnership with the FDA's Critical Path Initiative program. The non-profit company is based in Tucson, AZ, and operates from Ireland with additional staff in multiple other locations. The company's mission is to catalyze the development of new approaches that advance medical innovation and regulatory science, accelerating the path to a healthier world. The company orchestrates the development of drug development tools through an innovative, collaborative approach to the sharing of data and expertise, and accelerate the pace and reduce the costs of medical product development by building consensus among the participating institutions. The company was founded in 2005 by Raymond L. Woosley, Glenn C. Rice. Daniel M. Jorgensen has been the CEO of the company since 2022. | Commercial Services |
Finch Research & Development LLC
![]() Finch Research & Development LLC Pharmaceuticals: MajorHealth Technology Part of Finch Therapeutics Group, Inc., Finch Research & Development LLC provides biopharmaceutical services. The company is based in Cambridge, MA. Finch Research & Development was acquired by Finch Therapeutics, Inc. on October 23, 2017. | Health Technology |
Ocugen OpCo, Inc. |
- Börse
- Insiders
- Daniel M. Jorgensen
- Erfahrung